"Maybe they could answer the question, is the 95th biosimilar switching trial likely to show something different to the previous 94?" asks UK oncologist Dr Paul Cornes.

Latest Video
New Stories
-
Department to pay for Labor's Health Reform Commission
February 15, 2019 - - Latest News -
Department confirms 52 PBAC recommendations still unfunded
February 15, 2019 - - Latest News -
Is this an evidence-based system?
February 15, 2019 - - Latest News -
PHARMAC responds to criticism by announcing it will review itself
February 15, 2019 - - Latest News -
Offer a reduction and we will be more 'receptive'
February 14, 2019 - - Latest News -
Strong result for CSL
February 14, 2019 - - Latest News -
A relationship that just 'masks' a difficult reality
February 14, 2019 - - Comment